NO971003L - Enteral vaksine mot vaginale infeksjoner - Google Patents

Enteral vaksine mot vaginale infeksjoner

Info

Publication number
NO971003L
NO971003L NO971003A NO971003A NO971003L NO 971003 L NO971003 L NO 971003L NO 971003 A NO971003 A NO 971003A NO 971003 A NO971003 A NO 971003A NO 971003 L NO971003 L NO 971003L
Authority
NO
Norway
Prior art keywords
vaccine against
adjuvant
vaginal infections
enteral
against vaginal
Prior art date
Application number
NO971003A
Other languages
English (en)
Other versions
NO971003D0 (no
Inventor
Robert Llewellyn Clancy
Original Assignee
Auspharm Int Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Auspharm Int Ltd filed Critical Auspharm Int Ltd
Publication of NO971003D0 publication Critical patent/NO971003D0/no
Publication of NO971003L publication Critical patent/NO971003L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0002—Fungal antigens, e.g. Trichophyton, Aspergillus, Candida
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Fodder In General (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Enteral vaksine mot vaginale infeksjoner Enteral vaksine uten tilsetning av adjuvans omfattende en drept mikro- organisme som infiserer vagina. Mikro- organismen kan være en sopp, slik som Candida albicans, en bakterie, slik som Gardnerella vaginalls eller Nelsseria gonorrhoea, en protozo, slik som Tri- chomonas vaginalls, eller et virus, slik som Herpes genitalis. Fravær av adjuvans gir en signifikant forbedring med hensyn til fjerning av mikroorga- nismene sammenlignet med preparater med tilsetning av adjuvans.
NO971003A 1994-09-06 1997-03-05 Enteral vaksine mot vaginale infeksjoner NO971003L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9417880A GB9417880D0 (en) 1994-09-06 1994-09-06 Vaccine
PCT/IB1995/000766 WO1996007426A1 (en) 1994-09-06 1995-09-05 Enteral vaccine for vaginal infections

Publications (2)

Publication Number Publication Date
NO971003D0 NO971003D0 (no) 1997-03-05
NO971003L true NO971003L (no) 1997-05-06

Family

ID=10760876

Family Applications (1)

Application Number Title Priority Date Filing Date
NO971003A NO971003L (no) 1994-09-06 1997-03-05 Enteral vaksine mot vaginale infeksjoner

Country Status (12)

Country Link
EP (1) EP0779817A1 (no)
JP (1) JPH10505083A (no)
KR (1) KR970705409A (no)
CN (1) CN1159760A (no)
AU (1) AU3353095A (no)
CA (1) CA2199255A1 (no)
FI (1) FI970933L (no)
GB (1) GB9417880D0 (no)
IL (1) IL115197A (no)
NO (1) NO971003L (no)
WO (1) WO1996007426A1 (no)
ZA (1) ZA957482B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0834322A3 (en) * 1996-10-04 1998-04-22 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Mycosis vaccine
US7135191B2 (en) * 1997-09-04 2006-11-14 Zsolt Istvan Hertelendy Urogenital or anorectal transmucosal vaccine delivery system
EP1303300B1 (en) * 2000-06-19 2010-08-11 Hunter Immunology Limited Compositions and methods for treatment of candidiasis

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE841068A (fr) * 1975-04-25 1976-10-25 Procede de preparation de cristaux de poils gonococciques et leurs applications a la detection et a la prevention des infections dues a neisseria gonorrhoeae
ZA767577B (en) * 1976-01-29 1977-11-30 American Cyanamid Co Method of extracting and using antigen and products prepared therefrom
FR2397839A1 (fr) * 1977-07-18 1979-02-16 Grimberg Georges Compose donnant un vaccin oral intestinal
US4220638A (en) * 1978-10-12 1980-09-02 Merck & Co., Inc. Antigenic complex from N. Gonorrhoeae
US4443431A (en) * 1981-05-27 1984-04-17 The United States Of America As Represented By The Department Of Health And Human Services Neisseria gonorrhoeae vaccine
GB8506373D0 (en) * 1985-03-12 1985-04-11 Axon Healthcare Ltd Antigens antibodies
DD268868A1 (de) * 1987-04-03 1989-06-14 Forsch Lungenkrankheiten Und T Verfahren zur besseren herstellung lokal biologisch wirkender praeparate
US5512288A (en) * 1992-12-04 1996-04-30 University Technologies International, Inc. Giardia vaccine

Also Published As

Publication number Publication date
WO1996007426A1 (en) 1996-03-14
MX9701730A (es) 1997-10-31
EP0779817A1 (en) 1997-06-25
NO971003D0 (no) 1997-03-05
FI970933A0 (fi) 1997-03-05
GB9417880D0 (en) 1994-10-26
KR970705409A (ko) 1997-10-09
FI970933A7 (fi) 1997-05-05
CA2199255A1 (en) 1996-03-14
IL115197A0 (en) 1995-12-31
ZA957482B (en) 1997-03-06
IL115197A (en) 1999-07-14
JPH10505083A (ja) 1998-05-19
FI970933L (fi) 1997-05-05
AU3353095A (en) 1996-03-27
CN1159760A (zh) 1997-09-17

Similar Documents

Publication Publication Date Title
RU94042386A (ru) Вакцина против гепатита, содержащая 3-0-дезацилированный монофосфорил-липида, применение антигена гепатита для получения препарата для лечения гепатита, способ лечения гепатита
NZ337885A (en) vaccine formulation of an antigen, a TH-1 inducing adjuvant and a sparingly water soluble amino acid
BR9912653A (pt) Vìrus de herpes atenuado, cepa de vìrus, célula dendrìtica, processo para produzir um célula, composição farmacêutica, uso de um vìrus, e, processo para executar a terapia de gene em um paciente humano ou animal ou para tratar ou prevenir uma infecção patogênica ou câncer para tratar paciente animal
MXPA01013239A (es) Combinacion de bacterias de acido lactico y su uso para la prevencion y/o tratamiento de infecciones y condiciones inflamatorias.
DK0759089T3 (da) Behandling af glucaner med enzymer
MY110086A (en) Herpes simplex virus vaccines comrpising glycoprotein d and 3d-mpl
BR9712366A (pt) Gene de gd2 do vírus do herpes simples hsv2 isolado, plasmídeo compreendendo o mesmo, e, processos de induzir, em indivíduo, uma resposta imune contra hsv2 gd2, de tratar um indíviduo que está infectado com hsv, e, de prevenir que um indivíduo fique infectado com hsv
DE69839699D1 (de) Vaginales lactobacillus-medikament
RU95106823A (ru) Сукциноиламиногидроксиэтиламиносульфонамиды, фармацевтическая композиция, способ ингибирования ретровирусной протеазы, способ лечения ретровирусной инфекции способ лечения спида
AU5821000A (en) Vaccine
GR3017128T3 (en) Treatment of hiv infections and compounds useful therein.
EP0308066A3 (en) Promotion of host defense by systemic dsrna treatment
ATE279940T1 (de) Behandlung und prävention von helicobacter- infektionen
EP0733361A3 (en) Method for inactivating enveloped viruses and sperm
AU1001395A (en) Topically active compositions of double-stranded RNAs
DK312688A (da) Glykkopeptid-antibiotika
NO971003L (no) Enteral vaksine mot vaginale infeksjoner
NO960775L (no) Anvendelse av kinoksaliner i kombinasjon med proteaseinhibitorer som legemiddel for behandling av AIDS og/eller HIV-infeksjoner
PL326629A1 (en) Application of flupyrtin in prophylaxy and therapy of deseases associated with damaged hematopoietic cellular system
EA200200704A1 (ru) Ослабленные микроорганизмы для лечения инфекции
RU94031622A (ru) Гидрофильный бальзам для лечения и профилактики чесотки
EP1143981A4 (en) TREATMENT AND PREVENTION OF HIV AND OTHER VIRUS INFECTIONS
AU2211592A (en) Method of treatment for latent virus infection
NO930401L (no) Peptider som blokkerer hiv-infeksjoner og metoder for bruk derav
KR870009018A (ko) 단순 포진에 대한 왁진